ChromosOmics - Database

Icon by Leon Liehr                   

                                                  CHROMOSOME #13/21 -                                                 
UNCLEAR


Cases with unclear clinical correlation (U)

case no.
gender/
age at diagnosis

studied
material

de novo/
inherited

GTG-banding result
grade of mosaicism

final result of the sSMC
test
methods

clinical symptoms
Reference
13/21-
U-
1
n.a./
n.a.
n.a. n.a. n.a. mar(13 or 21) n.a. n.a. {17}
13/21-
U-
2
female/
prenatal
AF de novo 47,XX,+mar[100%] inv dup(13 or 21) FISH with all available centromeric probes AMA; no information about pregnancy outcome {10} case 6
13/21-
U-
3
n.a./
prenatal
AF n.a. n.a. min(13or21)(pterq10:) acro M n.a. AMA, ; no information about pregnancy outcome {9} case 4
13/21-
U-
4
female/
5m
PBL de novo 47,XX,r(13)(p11q34),+mar[100%] min(13 or 21) centromeric probe 13/21 delay of growth and development plus dysmorphic features "in concordance with a del(13qter) genotype" {12; 13}
13/21-
U-
5
see mult 2-12
13/21-
U-
6
see mult 2-13
13/21-
U-
7
male/
prenatal
AF de novo 47,XY,+mar[30%]/
46,XY[70%]
inv dup(13 or 21)(q10) FISH with all available centromeric probes AMA; child normal in ultrasound {16} case 2
13/21-
U-
8
see 13/21-der(18)-1
13/21-
U-
8a

see 13/21-der(18)-2
13/21-
U-
8b
see 13/21-der(18)-3
13/21-
U-
8c
see 13/21-der(18)-4
13/21-
U-
8d

see 13/21-der(18)-5
13/21-
U-
8e
see 13/21-der(18)-6
13/21-
U-
8f
see 13/21-der(18)-7
13/21-
U-
8g

see 13/21-der(18)-8
13/21-
U-
9 to

11
n.a./
n.a.
n.a. n.a. 47,+mar[?] mar(13 or 21) all centromeric probes n.a. {26} 3 cases
13/21-
U-
12
male/
prenatal
AF de novo 47,XY,+mar[14]/
46,XY[3]
inv dup(13 or 21)(q10) acro-cenM;
subcenM; UPD-test
AMA; no ultrasound abnormality in week 22; no further Information available. {0} provided by Dr. Schleussner,
Jena, Germany
13/21-
U-
13
male/
prenatal
AF de novo 47,XY,+mar[17]/
46,XY[7]
inv dup(13)(q11) or inv dup (21)(q11.1) acro-cenM;
subcenM;
UPD-test
AMA; too much amniotic fluid and pyelon enlargement, patient lost during follow up {0} provided by Dr. Kistner, Schwerin, Germany
13/21-
U-
14
female/
prenatal

AF
n.a. 47,XX,+mar[100%] inv dup(13)(q11) or inv dup (21)(q11.1) cenM;
subcenM
AMA; patient lost during follow up {0} provided by Carme Fuster, Barcelona, Spain
13/21-
U-
15
female/
prenatal

AF
n.a. 47,XX,+mar[12]/
46,XY[6]
inv dup(13)(q11) or inv dup (21)(q11.1) cenM;
subcenM
AMA; patient lost during follow up {0} provided by Carme Fuster, Barcelona, Spain
13/21-
U-
16
n.a./
prenatal
AF de novo 47,+mar[?%] mar(13 or 21) n.a. n.a.
{29}
13/21-
U-
17
female/
prenatal
AF de novo 47,XX,+mar[100%] min(13) (pterq11~12.1:) or min(21)(pterq11.1:) centromeric probes;
subcenM
AMA; patient lost during follow up {0} provided by Dr. Basaran (Turkey)
13/21-
U-
18 to

21
male/
prenatal
AF de novo 47,XY,+mar[100%] mar(13 or 21) centromeric probes patient lost during follow up or terminated {30} cases 28-29, 33, 36
13/21-
U-
22
female/
prenatal
AF n.a. 47,XX,+mar[15] inv dup(13 or 21)(q10) centromeric probes, subcenM AMA, patient lost during follow up or terminated {0} provided by Drs. Krause and Plonka, Potsdam, Germany
13/21-
U-
23
female/
stillborn
PBL n.a. 47,XX,+mar[100%] mar(13 or 21) cen13/21 normal at autopsy {19} case 10
13/21-
U-
24
female/
prenatal
AF de novo 47,XX,+mar[100%] mar(13 or 21) cen13/21 normal at autopsy {23} case 9
13/21-
U-
25 to

26
n.a./
n.a.
n.a. n.a. 47,+mar[?%] mar(13 or 21) n.a. normal at autopsy {33} 2 cases
13/21-
U-
27
see 13/21-U-8b {32}
13/21-
U-
28
see 13/21-U-8c {0}
{36}
{41} case 16
13/21-
U-
29 to 30
n.a./
n.a.
n.a. n.a. 47,+mar[?%] mar(13 or 21) centromeric probes no info available {45} 2 cases
13/21-
U-
31
n.a./
prenatal
AF n.a. 47,+mar[?%] mar(13 or 21) SKY, cep probes no info available {37} 1 new case
13/21-
U-
32
n.a./
postnatal
AF n.a. 47,+mar[24%]/
46[76%]
mar(13 or 21) n.a. subcenM with 3 BACs
Mild dysmorphic features; normal head ultrasound; normal renal ultrasound; normal development at 6 months of age
{38} case 26
13/21-
U-
33
n.a./
prenatal
AF n.a.
47,+mar[?%]
mar(13 or 21) n.a. n.a. {44} 1 case
13/21-
U-
34
see +15-13/21-1 {0} provided by Dr. Petersen, Athens, Greece
13/21-
U-
35
see +0Xm-13/21-1 {46} case 8
13/21-
U-
36
female/
prenatal
AF n.a. 47,XX,+mar[40%]/
46,XX[60%]
inv dup(13 or 21)(q10) acro-cenM;
subcenM
AMA - no further info available {0} provided by Dr. Belitz , Berlin, Germany
13/21-
U-
37
male/
prenatal
AF de novo 47,XY,+mar[100%] inv dup(13 or 21)(q10) acro-cenM;
subcenM
white spot in sonography, no further info {0} provided by Dr. Kobelt, Chemnitz, Germany
13/21-
U-
38
female/
prenatal
AF n.a. 47,XX,+mar[50%]/
46,XX[50%]
min(13)(:p11.1q11:) or min(21)(:p11.1q11.1:) cenM;
subcenM
AMA, no further info {0} provided by Dr. Mehnert, Neu-Ulm, Germany
13/21-
U-
39
female/
prenatal
AF n.a. 47,XX,+mar[100%]
inv dup(13 or 21)(q10)
acro-cenM;
subcenM
no further info {0} provided by Dr. M.B. Petersen, Athens, Greece
13/21-
U-
40
male/
prenatal
AF n.a. 47,XY,+mar[100%] r(13)(:p11.2q11:) or r(21)(:p11.2q11.1:) acro-cenM;
subcenM
no further info {0} provided by Dr. Alves, Portugal
13/21-
U-
41
male/
prenatal
AF n.a. 47,XY,+mar[100%] inv dup(13 or 21)(q10) acro-cenM;
subcenM
AMA, no further info {0} provided by Dr. Bartels, Göttingen, Germany
13/21-
U-
42
male/
prenatal
AF n.a. 47,XY,+mar[100%] inv dup(13 or 21)(q10) acro-cenM;
subcenM
AMA, no further info {0} provided by Dr. Alves, Portugal
13/21-
U-
43
n.a./
prenatal
AF n.a. 47,XN,+mar[100%] inv dup(13 or 21)(q10) acro-cenM;
subcenM
AMA, no further info {0} provided by Dr. Borochowitz, Israel
13/21-
U-
44
female/
prenatal
AF n.a.
47,XX,+mar[50%]/
46,XX[50%]
min(13)(pterq11:) or min(21)(pterq11.1:) acro-cenM;
subcenM
AMA, no further info {0} provided by Dr. Alves, Portugal
13/21-
U-
45
female/
prenatal
AF n.a. 47,XY,+mar[13]/
46,XY[2]
inv dup(13 or 21)(q10) acro-cenM;
subcenM
AMA, no further info {0} provided by Dr. Alves, Portugal
13/21-
U-
46
female/
prenatal
AF n.a. 47,XX,+mar[100%] inv dup(13 or 21)(q10) acro-cenM;
subcenM
AMA, no further info {0} provided by Dr. Huhle, Leipzig, Germany
13/21-
U-
47
male/
prenatal
AF de novo 47,XY,+mar[100%] inv dup(13 or 21)(q10) acro-cenM;
subcenM
AMA, no further info {0} provided by Dr. Alves, Portugal
13/21-
U-
48
n.a. AF n.a. n.a. mar(13 or 21) cep probes n.a. {54} 1 case
13/21-
U-
49
male/
prenatal
AF n.a. 47,XY,+mar[5]/
46,XY[73]
min(13)(pter→q11:) or min(21)(pter→q11.1:) acro-cenM;
subcenM
AMA, no further info {0} Dr. Alica Valachova, Trencin, Slovakia
13/21-
U-
50
see mult 2-48
13/21-
U-
51
n.a./
prenatal
PBL n.a. 47,XN,+mar[100%] inv dup(13 or 21)(q10) acro-cenM AMA {0} provided by Dr.Vesic, Belgrade, Serbia
13/21-
U-
52
male/
prenatal
AF n.a. 47,XY+mar[17]/
46,XY[33]
inv dup(13 or 21)(q10) acro-cenM AMA {0} provided from Leipzig, Germany
13/21-
U-
53
male/
prenatal
AF n.a. 48,XY,+mar1+mar2[24]/
46,XY[44]
inv dup(13 or 21)(q10) acro-cenM AMA {0} provided from Würzburg, Germany
13/21-
U-
54
female/
prenatal
AF n.a. 47,XX,+mar[10]/
46,XX[40]
inv dup(13 or 21)(q10) acro-cenM n.a. {0} provided from Greece
13/21-
U-
55
male/
newborn
PBL n.a. 47,XY,+mar[100%] inv dup(13 or 21)(q10) acro-cenM DD and DYS {0} provided from Tübingen, Germany

Cases with complex sSMC (Uc)

case no.
gender/
age at diagnosis

studied
material

de novo/
inherited

GTG-banding result
grade of mosaicism

final result of the sSMC
test
methods

clinical symptoms
Reference
13/21-
Uc-
1
female/
adult
PBL
cell line at ECACC DD1175
maternal 47,XX,+mar[27]/
46,XX[4]
dic(13 or 21;14)(q10;q10)* all available centromeric probes mother and daughter both adult and normal, Daughter was studied due to history of miscarriages {19} case 26
{39} case 107
{52}
13/21-
Uc-
2
female/
prenatal
AF maternal 47,XX,+mar[100%] dic(13 or 21;15)(q10;q10)* centromeric probes mother normal and child normal at 5 y {28} case 6; {52}
13/21-
Uc-
3
male/
adult
PBL
sperm
n.a. 46,XY,t(13;21)(q11;q11.1)
leeds to der(13;21) in offspring
n.a. normal male, infertile {57} 1 case
13/21-
Uc-
4
male/
adult
PBL
n.a. 46,XY,t(13;14)(q10;p11.1)
leeds to der(13;14) in offspring
n.a. normal male, infertile {0} provided from Spain

Cases with discontinous sSMC (Ud)

case no.
gender/
age at diagnosis

studied
material

de novo/
inherited

GTG-banding result
grade of mosaicism

final result of the sSMC
test
methods

clinical symptoms
Reference
13/21-
Ud-
1
-
-
-
-
-
-
-
-

Cases with UPD (Uu)

case no.
gender/
age at diagnosis

studied
material

de novo/
inherited

GTG-banding result
grade of mosaicism

final result of the sSMC
test
methods

clinical symptoms
Reference
13/21-
Uu-
1
-
-
-
-
-
-
-
-